助手标题
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
共[35]条 当前为第1条到20条
 

相关语句
未完全匹配句对
    Conclusion Transdermal fentanyl in pain treatment after interventional therapy for liver cancer has reliable efficacy,safety and less incident of adverse effects.
    结论芬太尼透皮贴剂用于治疗肝癌介入治疗后疼痛,疗效确切,安全可靠,不良反应小。
    CLINICAL EVALUATION OF ANALGESIC EFFECT OF TRANSDERMAL FENTANYL ON CANCER PAIN
    芬太尼透皮贴剂用于癌症止痛临床效果评价
    Clinical Application of Transdermal Fentanyl (Durogesic) for 67 Patients with Cancer Pain
    芬太尼透皮贴剂(多瑞吉)治疗癌痛临床应用67例观察
    Clinical Study of Transdermal Fentanyl in Treatment of Cancer Pain
    芬太尼透皮贴剂治疗癌症疼痛的临床应用
    Transdermal Fentanyl-Duragesic in Treatment of Cancer Pain(A Report of 52Cases)
    芬太尼贴剂(多瑞吉)治疗晚期癌症疼痛患者52例
    TRANSDERMAL FENTANYL FOR THE TREATFMENT OF CANCER PAIN IN 46 CASES
    芬太尼透皮贴治疗癌性疼痛46例疗效观察
    The clinical use of transdermal fentanyl in treatment of cancer pain of lung cancer.
    芬太尼透皮贴剂治疗肺癌癌痛疗效分析
    A clinical study on the transdermal fentanyl used for postoperative pain relief
    透皮芬太尼贴剂用于术后镇痛的临床研究
    The Effects of Transdermal Fentanyl on 136 Patients with Moderate or Severe Cancer Pain
    芬太尼透皮贴剂治疗136例中重度癌痛疗效观察
    The treatment of cancer pain in morphine pretreated and opioid naIve patients with Transdermal Fentanyl
    芬太尼透皮贴剂在未用过阿片类药物与使用过吗啡治疗的癌痛患者中的应用
    Clinical observation of transdermal Fentanyl and Morphine controlled-release tablets used in patient with cancer pain
    芬太尼透皮贴剂与吗啡控释片治疗癌痛的临床观察
    Transdermal fentanyl for the management of cancer pain:A survey of 4492 patients
    芬太尼透皮贴剂治疗4492例癌痛的临床疗效分析
    Transdermal fentanyl for the treatment of cancer pain
    芬太尼透皮贴剂治疗癌痛
    Study on the curative effect of transdermal fentanyl in pain treatment after interventional therapy for liver cancer
    芬太尼透皮贴剂在肝癌介入治疗后疼痛的疗效观察
    86.2% patients preferred to receive transdermal fentanyl.
    86 2 %病人选择继续用芬太尼透皮贴剂。
    The median dosage of transdermal fentanyl is 7.5mg. The range of dosage was from 2.5mg to 7.5mg in 92.9% patients.
    芬太尼的中位剂量7.5mg,其中92.9%患者在2.5~10mg之内。
    Objective To evaluate the efficacy and safety of Transdermal Fentanyl in the treatment of opioid naIve and morphine pretreated cancer patients.
    目的评价未接受过阿片类药物与使用过吗啡治疗的肿瘤患者使用芬太尼透皮贴剂治疗癌痛的疗效和安全性。
    No severe side effects were noted. Conclusion The Ⅳ morphine / transdermal fentanyl conversion ratio is 31 (mg·day-1) : 1(mg·day-1) .
    结论 静脉吗啡日消耗量(mg/d)与芬太尼贴剂(mg/d)的转换比例是31:1。
    86.2% patients preferred continue treated by transdermal fentanyl.
    86.2%病人选择继续用芬太尼透皮贴剂。
    METHODS:30patients with pate squamous carcinoma and serious membrana mucosa ulcerate and pain after a whole range radiotherapy,who were treated with3to5patches2.5mg(25μg/h)of transdermal fentanyl every9~15days if their VAS scores were found to be more than6scores.
    方法:头颈部鳞癌接受全程放疗过程中出现严重口咽部粘膜溃烂伴疼痛患者30例,其直观模拟标度尺评分法(VAS)评分≥6分时,给予芬太尼透皮贴2.5mg(25μg/h)3贴~5贴/9d~15d。
 

首页上一页12下一页尾页 

 
CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社